MFDS — authorised 11 August 2004
- Marketing authorisation holder: HAMELN PHARMA PLUS
- Status: likely_approved
🇰🇷 Pentetate Calcium Trisodium in South Korea
MFDS authorised Pentetate Calcium Trisodium on 11 August 2004
Marketing authorisation
Pentetate Calcium Trisodium in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in South Korea
Frequently asked questions
Is Pentetate Calcium Trisodium approved in South Korea?
Yes. MFDS authorised it on 11 August 2004.
Who is the marketing authorisation holder for Pentetate Calcium Trisodium in South Korea?
HAMELN PHARMA PLUS holds the South Korean marketing authorisation.